1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Gaspari, Z. Patthy, A. Graf, L. Perczel, A. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking IX Eur.J.Biochem. EJBCAI 0262 0014-2956 269 527 537 10.1046/j.0014-2956.2001.02685.x 11856311 Comparative structure analysis of proteinase inhibitors from the desert locust, Schistocerca gregaria. 2002 10.2210/pdb1kj0/pdb pdb_00001kj0 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 1 SINGLE WAVELENGTH M 1 1.0 3828.314 SERINE PROTEASE INHIBITOR I Residues 20-54 1 syn polymer SCHISTOCERCA GREGARIA TRYPSIN INHIBITOR (SGTI) no no EQECTPGQTKKQDCNTCNCTPTGVWACTRKGCPPH EQECTPGQTKKQDCNTCNCTPTGVWACTRKGCPPH A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n database_2 pdbx_struct_assembly pdbx_struct_oper_list repository Initial release Version format compliance Version format compliance Database references Derived calculations 1 0 2001-12-12 1 1 2008-04-27 1 2 2011-07-13 1 3 2022-02-23 _database_2.pdbx_DOI _database_2.pdbx_database_accession SOLUTION STRUCTURE OF THE SMALL SERINE PROTEASE INHIBITOR SGCI[L30R, K31M] SOLUTION STRUCTURE OF THE SMALL SERINE PROTEASE INHIBITOR SGCI PROTEINASE INHIBITOR PMP-C (NMR, 36 STRUCTURES) RCSB Y RCSB 2001-12-04 REL REL SOLID PHASE PEPTIDE SYNTHESIS, FMOC STRATEGY, SEQUENCE NATURALLY FOUND IN SCHISTOCERCA GREGARIA (DESERT LOCUST) sample structures with acceptable covalent geometry, structures with the least restraint violations 100 10 2D NOESY 0 3.0 ambient 300 K the structures are based on a total of 342 NOE distance restraints (108 long-range) simulated annealing 6 closest to the average 2.4mM SGTI NA 90% H2O/10% D2O Brunger refinement X-PLOR 3.851 Brunger structure solution X-PLOR 3.851 500 Bruker DRX GLU 1 n 1 GLU 1 A GLN 2 n 2 GLN 2 A GLU 3 n 3 GLU 3 A CYS 4 n 4 CYS 4 A THR 5 n 5 THR 5 A PRO 6 n 6 PRO 6 A GLY 7 n 7 GLY 7 A GLN 8 n 8 GLN 8 A THR 9 n 9 THR 9 A LYS 10 n 10 LYS 10 A LYS 11 n 11 LYS 11 A GLN 12 n 12 GLN 12 A ASP 13 n 13 ASP 13 A CYS 14 n 14 CYS 14 A ASN 15 n 15 ASN 15 A THR 16 n 16 THR 16 A CYS 17 n 17 CYS 17 A ASN 18 n 18 ASN 18 A CYS 19 n 19 CYS 19 A THR 20 n 20 THR 20 A PRO 21 n 21 PRO 21 A THR 22 n 22 THR 22 A GLY 23 n 23 GLY 23 A VAL 24 n 24 VAL 24 A TRP 25 n 25 TRP 25 A ALA 26 n 26 ALA 26 A CYS 27 n 27 CYS 27 A THR 28 n 28 THR 28 A ARG 29 n 29 ARG 29 A LYS 30 n 30 LYS 30 A GLY 31 n 31 GLY 31 A CYS 32 n 32 CYS 32 A PRO 33 n 33 PRO 33 A PRO 34 n 34 PRO 34 A HIS 35 n 35 HIS 35 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 1 A A O H CYS ALA 17 26 1.46 1 A A O H THR THR 20 22 1.58 3 A A O H ASP ASN 13 15 1.52 4 A A O H CYS ALA 17 26 1.51 7 A A O H CYS ALA 17 26 1.59 8 A A O HG1 GLN THR 8 9 1.52 10 A A OE1 H GLU CYS 3 4 1.43 1 A ARG 29 0.264 SIDE CHAIN 2 A ARG 29 0.283 SIDE CHAIN 3 A ARG 29 0.288 SIDE CHAIN 4 A ARG 29 0.215 SIDE CHAIN 5 A ARG 29 0.263 SIDE CHAIN 6 A ARG 29 0.219 SIDE CHAIN 7 A ARG 29 0.193 SIDE CHAIN 8 A ARG 29 0.237 SIDE CHAIN 9 A ARG 29 0.313 SIDE CHAIN 10 A ARG 29 0.302 SIDE CHAIN 1 A GLU 3 178.07 -27.61 1 A THR 5 -167.05 -55.40 1 A PRO 6 -59.06 -96.32 1 A ASP 13 59.32 126.77 1 A CYS 14 78.17 -28.87 1 A ASN 18 58.63 142.99 1 A PRO 21 -67.87 55.89 1 A THR 22 174.03 28.89 1 A VAL 24 -29.57 126.85 1 A LYS 30 -136.33 -60.37 2 A GLN 2 -144.41 22.50 2 A GLU 3 -177.47 -30.63 2 A CYS 4 66.97 176.45 2 A THR 5 -161.98 -57.68 2 A PRO 6 -65.30 1.67 2 A GLN 8 -147.78 14.70 2 A THR 9 37.31 94.46 2 A GLN 12 -131.06 -67.16 2 A ASP 13 -174.02 -131.79 2 A CYS 14 -33.57 -38.12 2 A PRO 21 -75.82 47.71 2 A THR 22 164.67 42.09 2 A VAL 24 71.42 -5.05 2 A TRP 25 36.26 -153.79 2 A ALA 26 -140.04 -64.19 2 A CYS 27 59.45 110.92 2 A THR 28 -81.11 -151.43 2 A CYS 32 57.75 139.33 3 A CYS 4 176.24 167.04 3 A THR 5 -127.10 -165.34 3 A THR 9 -177.14 131.89 3 A ASP 13 -42.46 93.62 3 A CYS 14 63.65 -54.00 3 A ASN 15 -52.89 88.37 3 A PRO 21 -69.46 59.69 3 A THR 22 161.63 36.02 3 A VAL 24 50.08 176.78 3 A TRP 25 -152.61 -158.16 3 A ALA 26 -177.92 85.30 3 A LYS 30 177.25 90.26 3 A PRO 34 -74.17 -88.86 4 A GLN 2 -176.98 132.86 4 A GLU 3 -132.70 -64.14 4 A THR 5 -165.48 -58.29 4 A THR 9 60.53 143.42 4 A LYS 10 -138.16 -39.02 4 A LYS 11 66.45 -78.74 4 A GLN 12 45.39 89.08 4 A ASP 13 57.22 -150.02 4 A ASN 18 51.08 93.24 4 A CYS 19 -50.42 172.10 4 A THR 22 167.37 35.75 4 A VAL 24 -164.35 -35.97 4 A TRP 25 60.73 175.67 4 A ALA 26 -131.47 -53.27 4 A CYS 27 61.48 127.19 4 A ARG 29 58.62 155.43 4 A LYS 30 43.64 -96.89 5 A GLN 2 -171.53 125.10 5 A CYS 4 179.68 154.04 5 A THR 5 -170.56 52.50 5 A PRO 6 -94.59 -62.64 5 A GLN 8 -114.39 -144.83 5 A THR 9 -149.74 -146.47 5 A LYS 10 -173.20 102.18 5 A GLN 12 43.12 -147.42 5 A ASP 13 -63.06 -134.89 5 A ASN 18 -163.35 119.21 5 A THR 22 168.93 29.23 5 A CYS 27 57.00 107.60 5 A ARG 29 58.84 106.30 5 A LYS 30 -176.90 -37.41 6 A GLU 3 -178.16 -31.14 6 A THR 5 -163.17 -57.02 6 A PRO 6 -78.22 28.01 6 A THR 9 50.24 107.26 6 A GLN 12 37.11 -142.59 6 A ASP 13 -127.83 -100.53 6 A PRO 21 -75.35 46.09 6 A THR 22 177.49 30.26 6 A VAL 24 80.33 -31.27 6 A TRP 25 46.64 -171.88 6 A ALA 26 -156.16 -55.90 6 A CYS 27 63.32 121.79 7 A GLN 2 173.78 79.26 7 A CYS 4 83.55 178.34 7 A THR 5 -173.50 -55.38 7 A GLN 8 -62.37 -97.21 7 A THR 9 171.70 151.59 7 A LYS 11 -95.58 51.53 7 A ASP 13 41.88 -106.38 7 A ASN 18 57.49 114.31 7 A PRO 21 -69.04 54.35 7 A THR 22 163.28 37.27 7 A VAL 24 76.08 -11.29 7 A TRP 25 39.81 -149.70 7 A ALA 26 -135.20 -57.13 7 A CYS 27 57.62 100.30 7 A LYS 30 -171.27 -41.18 7 A CYS 32 50.34 -172.77 7 A PRO 34 -75.86 -92.52 8 A GLN 2 177.78 51.27 8 A THR 5 -168.29 -58.90 8 A GLN 8 -61.09 -141.88 8 A THR 9 -170.98 90.95 8 A GLN 12 -152.06 -45.73 8 A ASP 13 -165.48 -145.46 8 A ASN 18 40.05 106.35 8 A THR 22 163.02 36.09 8 A VAL 24 54.70 161.47 8 A CYS 27 63.01 89.97 8 A LYS 30 -141.25 15.55 9 A GLU 3 35.07 36.07 9 A CYS 4 91.10 169.22 9 A THR 5 -176.14 -57.14 9 A PRO 6 -73.80 35.16 9 A GLN 8 -96.52 47.62 9 A LYS 11 -54.51 86.44 9 A ASP 13 -139.24 -120.81 9 A THR 16 -104.37 79.77 9 A THR 22 164.07 45.49 9 A VAL 24 51.06 169.70 9 A ALA 26 -127.33 -65.53 9 A CYS 27 67.65 158.99 9 A ARG 29 -115.98 -141.91 9 A LYS 30 73.50 61.94 9 A PRO 34 -72.31 -84.11 10 A GLU 3 -143.37 -60.60 10 A THR 5 -153.88 -62.13 10 A THR 9 57.43 152.74 10 A LYS 10 -114.73 -149.86 10 A LYS 11 -155.47 66.94 10 A GLN 12 -98.99 36.66 10 A ASP 13 59.99 109.51 10 A CYS 14 66.61 -67.85 10 A ASN 15 -59.81 94.01 10 A PRO 21 -68.40 53.86 10 A THR 22 166.50 47.08 10 A VAL 24 67.11 -47.85 10 A TRP 25 60.28 -167.44 10 A ALA 26 -153.06 -53.30 10 A CYS 27 64.75 142.38 10 A LYS 30 -177.68 -45.95 SOLUTION STRUCTURE OF THE SMALL SERINE PROTEASE INHIBITOR SGTI 1 N N disulf 2.016 A CYS 4 A SG CYS 4 1_555 A CYS 19 A SG CYS 19 1_555 disulf 2.018 A CYS 14 A SG CYS 14 1_555 A CYS 32 A SG CYS 32 1_555 disulf 2.020 A CYS 17 A SG CYS 17 1_555 A CYS 27 A SG CYS 27 1_555 HYDROLASE serine protease inhibition, inhibitor specificity, HYDROLASE SGP1_SCHGR UNP 1 1 O46162 MKLALALCAAFLLVVLVQAEQECTPGQTKKQDCNTCNCTPTGVWACTRKGCPPHKREVTCEPGTTFKDKCNTCRCGSDGK SAACTLKACPQK 20 54 1KJ0 1 35 O46162 A 1 1 35